SCHEMBL27282968

SCHEMBL27282968

CC(C)COC1CCC(c2ccc(C(=O)O)cc2)CC1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 1/20 0.41
GPR119 Q8TDV5 1/20 0.41
CYP2D6 P10635 1/20 0.40
MAPK1 P28482 1/20 0.40
FFAR4 Q5NUL3 1/20 0.40
CYP2C9 P11712 1/20 0.40
HCRTR2 O43614 3/20 0.39
MAPT P10636 2/20 0.39
ACACB O00763 1/20 0.39
SRD5A2 P31213 1/20 0.39
NR1H4 Q96RI1 2/20 0.39
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
HAO1 Q9UJM8 1/20 0.38
DGAT1 O75907 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10240973 0.81 MRGPRX4 (0.44) MRGPRX4FFAR4CYP2C9MAPTKMT2A
SCHEMBL11190301 0.79 CA1 (0.44) MRGPRX4CYP2D6CYP2C9MAPTALDH1A1
SCHEMBL11190308 0.79 CA1 (0.44) MRGPRX4CYP2D6CYP2C9MAPTALDH1A1
SCHEMBL901207 0.78 TSHR (0.57) MRGPRX4CYP2C9MAPTSRD5A2ALDH1A1
SCHEMBL2321634 0.78 TSHR (0.57) MRGPRX4CYP2C9MAPTSRD5A2ALDH1A1
SCHEMBL901209 0.78 TSHR (0.57) MRGPRX4CYP2C9MAPTSRD5A2ALDH1A1
SCHEMBL600741 0.76 GPR119 (0.45) MRGPRX4GPR119CYP2C9HCRTR2MAPT
SCHEMBL600740 0.76 GPR119 (0.45) MRGPRX4GPR119CYP2C9HCRTR2MAPT
Hydrochloric Acid SCHEMBL4290507 0.76 TSHR (0.55) MRGPRX4CYP2C9MAPTSRD5A2ALDH1A1
SCHEMBL11155303 0.74 CYP2D6 (0.44) MRGPRX4CYP2D6CYP2C9MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026486-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 WO disclosed
WO-2024026484-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 WO disclosed